Lucid Diagnostics Inc. Quarterly Debt-to-equity in % from Q2 2022 to Q3 2024

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: Lucid Diagnostics Inc. quarterly Debt-to-equity history and growth rate from Q2 2022 to Q3 2024.
Lucid Diagnostics Inc. Debt-to-equity for the quarter ending September 30, 2024 was 264 %, a 88.4% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date
Q3 2024	264	+124	+88.4%	Sep 30, 2024
Q2 2024	351	+271	+341%	Jun 30, 2024
Q1 2024	396	+348	+725%	Mar 31, 2024
Q4 2023	278	+244	+724%	Dec 31, 2023
Q3 2023	140	+116	+480%	Sep 30, 2023
Q2 2023	79.4	+29.7	+59.6%	Jun 30, 2023
Q1 2023	48.1			Mar 31, 2023
Q4 2022	33.8			Dec 31, 2022
Q3 2022	24.1			Sep 30, 2022
Q2 2022	49.8			Jun 30, 2022

* An asterisk sign (*) next to the value indicates that the value is likely invalid.